Health In Tech (HIT) & Its Peers Critical Analysis

Health In Tech (NASDAQ:HIT) is one of 93 public companies in the “Healthcare Technology” industry, but how does it compare to its rivals? We will compare Health In Tech to related businesses based on the strength of its earnings, valuation, risk, profitability, analyst recommendations, institutional ownership and dividends.

Profitability

This table compares Health In Tech and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Health In Tech	N/A	N/A	N/A
Health In Tech Competitors	-762.90%	-30.85%	-15.65%

Risk and Volatility

Health In Tech has a beta of 3.02, indicating that its stock price is 202% more volatile than the S&P 500. Comparatively, Health In Tech’s rivals have a beta of 1.11, indicating that their average stock price is 11% more volatile than the S&P 500.

Institutional and Insider Ownership

42.4% of shares of all “Healthcare Technology” companies are owned by institutional investors. 71.0% of Health In Tech shares are owned by company insiders. Comparatively, 16.2% of shares of all “Healthcare Technology” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares Health In Tech and its rivals top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Health In Tech	$32.83 million	N/A	-8.67
Health In Tech Competitors	$352.08 million	-$24.15 million	12.73

Health In Tech’s rivals have higher revenue, but lower earnings than Health In Tech. Health In Tech is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Analyst Recommendations

This is a summary of current ratings and target prices for Health In Tech and its rivals, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Health In Tech	1	0	1	1	2.67
Health In Tech Competitors	451	1533	2743	89	2.51

Health In Tech presently has a consensus price target of $3.50, indicating a potential upside of 476.61%. As a group, “Healthcare Technology” companies have a potential upside of 45.11%. Given Health In Tech’s stronger consensus rating and higher possible upside, research analysts clearly believe Health In Tech is more favorable than its rivals.

Summary

Health In Tech beats its rivals on 8 of the 12 factors compared.

About Health In Tech

Health in Tech, Inc. engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.